Clinical Trials Browser

Enrolling by invitation × Lymphoma, B-Cell, Marginal Zone × 1 year × Clear all

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT07168486 2025-09-11

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Phase 1 Enrolling by invitation

15 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Clinical Trials

Watch and Wait or Worry and Wait in Indolent Lymphoma

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas